Insight Genetics Gets Contract From NCI to Develop New Lung Cancer Test

Insight Genetics Tuesday announced that it has been awarded a $200,000 Phase I Small Business Innovation Research contract from the National Cancer Institute (NCI) to develop a new test for lung cancer patients.
FreshNews